© 2003 The Royal College of Psychiatrists
Diet, smoking and cardiovascular risk in people with schizophrenia
Descriptive study
Department of Clinical Research, Crichton Royal Hospital, Dumfries DG1 4TG, UK.
Correspondence: Tel: +44 1387 244000; fax: +44 1387 257735; e-mail: rgmccreadie_crh{at}compuserve.com
Declaration of interest Funded by Chief Scientist Offi, Scottish Executive.
Background Physical health of people with schizophrenia is poor and they die early from cardiovascular disease.
Aims To describe the lifestyle of people with schizophrenia through diet, smoking habits, weight and exercise, and to report risk of coronary heart disease (CHD).
Method Dietary habits of 102 community-dwelling people with schizophrenia were assessed by the Scottish Health Survey Questionnaire. Also assessed were smoking habits, physical activity, biochemical indices of nutrition and future risk of CHD.
Results Fewer males, compared with the general population, reached
acceptable levels for consumption of fruit, vegetables, milk, potatoes and
pulses. Fewer females reached the levels for consumption of milk and potatoes.
Mean number of fruit and vegetable portions consumed per week was 16
(s.d.=14); 71 (70%) were smokers; 25 (86%) females and 50 (70%) males were
over weight or obese; 59 (59%) considered themselves physically active; 46
(53%) had a raised cholesterol: high-density lipoprotein ratio, and 64 (74%) a
low 
-tocopherol: cholesterol ratio. Mean 10-year risk of CHD in males
was 10.5% (s.d.=8) and in females 7% (s.d.=6).
Conclusions The lifestyle of people with schizophrenia must give cause for concern in relation to CHD. Care from concern in relation to secondary care services must address physical as well as mental health.
Related articles in BJP:
- Highlights of this issue
BJP 2003 183: 477-a23.[Full Text]
This article has been cited by other articles:
 |
|
 |
|
  R. Hempel, J. Tulen, N. van Beveren, C. Roder, and M. Hengeveld Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia J Psychopharmacol, August 1, 2009; 23(6): 697 - 707. [Abstract] [PDF]
|
|
|
|
 |
|
 K. T. Praveen, S. N. C. Kudlur, R. P. Hanabe, and A. T. Egbewunmi Staff attitudes to smoking and the smoking ban Psychiatr. Bull., March 1, 2009; 33(3): 84 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hamer, E. Stamatakis, and A. Steptoe Psychiatric Hospital Admissions, Behavioral Risk Factors, and All-Cause Mortality: The Scottish Health Survey Arch Intern Med, December 8, 2008; 168(22): 2474 - 2479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hammerman, J. Dreiher, S. H Klang, H. Munitz, A. D Cohen, and M. Goldfracht Antipsychotics and Diabetes: An Age-Related Association Ann. Pharmacother., September 1, 2008; 42(9): 1316 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kreyenbuhl, L. B. Dixon, J. F. McCarthy, S. Soliman, R. V. Ignacio, and M. Valenstein Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia? Schizophr Bull, August 20, 2008; (2008) sbn106v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Buckley, A. Foster, and B. Miller Schizophrenia Host Vulnerability and Risk of Metabolic Disturbances During Treatment with Antipsychotics Focus, April 1, 2008; 6(2): 172 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fell, J. Neill, N. Anjum, L. Peltola, and K. Marshall Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats J Psychopharmacol, March 1, 2008; 22(2): 182 - 186. [Abstract] [PDF]
|
|
|
|
|
|
E. Sacchetti, G. Trifiro, A. Caputi, C. Turrina, E. Spina, C. Cricelli, O. Brignoli, E. Sessa, and G. Mazzaglia Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects J Psychopharmacol, January 1, 2008; 22(1): 39 - 46. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Hippisley-Cox, Y. Vinogradova, C. Coupland, and C. Parker Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder: Nested Case-Control Study Arch Gen Psychiatry, December 1, 2007; 64(12): 1368 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sarandol, S. Kirli, C. Akkaya, N. Ocak, E. Eroz, and E. Sarandol Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment J Psychopharmacol, November 1, 2007; 21(8): 857 - 863. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Leas and M. Mccabe Health Behaviors among Individuals with Schizophrenia and Depression J Health Psychol, July 1, 2007; 12(4): 563 - 579. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Byrne Managing the acute psychotic episode BMJ, March 31, 2007; 334(7595): 686 - 692. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Goldbloom and P. Kurdyak Mental illness and cardiovascular mortality: searching for the links Can. Med. Assoc. J., March 13, 2007; 176(6): 787 - 788. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Archie, J. O. Goldberg, N. Akhtar-Danesh, J. Landeen, L. McColl, and J. McNiven Psychotic Disorders, Eating Habits, and Physical Activity: Who Is Ready for Lifestyle Changes? Psychiatr Serv, February 1, 2007; 58(2): 233 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. J. Osborn, G. Levy, I. Nazareth, I. Petersen, A. Islam, and M. B. King Relative Risk of Cardiovascular and Cancer Mortality in People With Severe Mental Illness From the United Kingdom's General Practice Research Database Arch Gen Psychiatry, February 1, 2007; 64(2): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jochelson Smoke-free legislation and mental health units: the challenges ahead The British Journal of Psychiatry, December 1, 2006; 189(6): 479 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Citrome, A. Jaffe, J. Levine, and D. Martello Incidence, Prevalence, and Surveillance for Diabetes in New York State Psychiatric Hospitals, 1997-2004 Psychiatr Serv, August 1, 2006; 57(8): 1132 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Horvitz-Lennon, A. M. Kilbourne, and H. A. Pincus From silos to bridges: meeting the general health care needs of adults with severe mental illnesses. Health Aff., May 1, 2006; 25(3): 659 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. J. OSBORN, I. NAZARETH, and M. B. KING Risk for coronary heart disease in people with severe mental illness: Cross-sectional comparative study in primary care The British Journal of Psychiatry, March 1, 2006; 188(3): 271 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Llorente and V. Urrutia Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications Clin. Diabetes, January 1, 2006; 24(1): 18 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Liperoti, C. Pedone, K. L. Lapane, V. Mor, R. Bernabei, and G. Gambassi Venous Thromboembolism Among Elderly Patients Treated With Atypical and Conventional Antipsychotic Agents Arch Intern Med, December 12, 2005; 165(22): 2677 - 2682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dursun, T. G. Dinan, C. Bushe, and J. Thakore Challenges in advancing mental and physical health of patients with serious mental illness J Psychopharmacol, November 1, 2005; 19(6_suppl): 3 - 5. [PDF]
|
|
|
|
|
|
C. Bushe, P. Haddad, R. Peveler, and J. Pendlebury The role of lifestyle interventions and weight management in schizophrenia J Psychopharmacol, November 1, 2005; 19(6_suppl): 28 - 35. [Abstract] [PDF]
|
|
|
|
|
|
C. Bushe and C. Paton The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link? J Psychopharmacol, November 1, 2005; 19(6_suppl): 76 - 83. [Abstract] [PDF]
|
|
|
|
|
|
L. Citrome Metabolic Syndrome and Cardiovascular Disease J Psychopharmacol, November 1, 2005; 19(6_suppl): 84 - 93. [Abstract] [PDF]
|
|
|
|
|
|
L. Citrome and D. Yeomans Do guidelines for severe mental illness promote physical health and well-being? J Psychopharmacol, November 1, 2005; 19(6_suppl): 102 - 109. [Abstract] [PDF]
|
|
|
|
|
|
M. J. GOLDACRE, L. M. KURINA, C. J. WOTTON, D. YEATES, and V. SEAGROAT Schizophrenia and cancer: an epidemiological study The British Journal of Psychiatry, October 1, 2005; 187(4): 334 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. McCREADIE, C. KELLY, M. CONNOLLY, S. WILLIAMS, G. BAXTER, M. LEAN, and J. R. PATERSON Dietary improvement in people with schizophrenia: Randomised controlled trial The British Journal of Psychiatry, October 1, 2005; 187(4): 346 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Greening Physical health of patients in rehabilitation and recovery: asurveyofcasenoterecords Psychiatr. Bull., June 1, 2005; 29(6): 210 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Connolly and C. Kelly Lifestyle and physical health in schizophrenia Adv. Psychiatr. Treat., March 1, 2005; 11(2): 125 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. S. Kumar Physical illness and schizophrenia The British Journal of Psychiatry, June 1, 2004; 184(6): 541 - 541. [Full Text] [PDF]
|
|